Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vascular Solutions developed and commercialized over ninety proprietary medical devices for minimally invasive coronary and peripheral vascular procedures. The company demonstrated strong revenue growth, with annual sales exceeding $150 million prior to its acquisition. Its products were widely adopted by interventional cardiologists, radiologists, electrophysiologists, and vein specialists globally. Clinical studies supported the safety and effectiveness of key products such as guidewires, microcatheters, and guide extensions for complex interventions like CTO PCI. The company was acquired by Teleflex in a $1 billion deal that closed in early 2017.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vascular Solutions.